Document Detail

An update on drug-eluting stents.
MedLine Citation:
PMID:  23192748     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Coronary artery disease remains one of the major causes of morbidity and mortality worldwide. Percutaneous coronary intervention has been shown to be an effective treatment for angina pectoris, although it does not provide any prognostic benefit in stable patients. Drug-eluting stents (DES) have revolutionised the practice of interventional cardiology by permitting the percutaneous treatment of increasingly complex coronary artery lesions, which historically would have only been treated with surgery. There have been concerns with their long-term safety; however, the most recent large meta-analysis appears to suggest that these concerns are no longer a pertinent issue with the newest generation of stents. Consequently, DES are being used in complex patients and lesion types, and clinical data and guideline recommendations support this. New stent designs are also continually being developed, with the aim to further improve the safety profile of these devices. It must, however, be kept in mind that complacency following the impressive result from initial DES studies lead to, amongst others things, sub-optimal and careless stent deployment, and inappropriate patient selection, which may have ultimately contributed to the prior safety concerns. It is vital, therefore, that this is not repeated in light of the reassuring data, or with newer devices. Finally, as stent design improves, it is becoming increasingly difficult to identify meaningful and clinically relevant differences in stent performance without the requirement of a very large, expensive, randomised trial.
Scot Garg; Patrick W Serruys
Related Documents :
24637028 - Pulmonary hypertension after pneumonectomy for lung cancer.
24688228 - Shape of the dilated aorta in children with bicuspid aortic valve.
24835048 - Optic chiasm compression from mass effect and thrombus formation following unsuccessful...
23463758 - De novo and recurrent aneurysms in pediatric patients with cerebral aneurysms.
24436598 - Endovascular repair of a traumatic thoracic aortic injury resulting in late aortic dila...
20667198 - The accuracy of plain skull x-ray examination as a predictor of recanalization followin...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current treatment options in cardiovascular medicine     Volume:  15     ISSN:  1092-8464     ISO Abbreviation:  Curr Treat Options Cardiovasc Med     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-28     Completed Date:  2013-01-29     Revised Date:  2013-07-25    
Medline Journal Info:
Nlm Unique ID:  9815942     Medline TA:  Curr Treat Options Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  61-78     Citation Subset:  -    
Department of Cardiology, East Lancashire NHS Trust, Haslingden Road, Blackburn, Lancashire, UK, BB2 3HH,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Is There Still a Role for Fibrinolysis in ST-Elevation Myocardial Infarction?
Next Document:  Morphology and SSU rRNA gene-based phylogeny of two Diophrys-like ciliates from northern china, with...